Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

American journal of respiratory and critical care medicine - 15 Jun 2008

Sztrymf Benjamin, Coulet Florence, Girerd Barbara, Yaici Azzedine, Jais Xavier, Sitbon Olivier, Montani David, Souza Rogério, Simonneau Gerald, Soubrier Florent, Humbert Marc

Abstract excerpt

RATIONALE: Germline mutations in the gene encoding for bone morphogenetic protein receptor 2 (BMPR2) are a cause of pulmonary arterial hypertension (PAH). OBJECTIVES: We conducted a study to determine the influence, if any, of a BMPR2 mutation on clinical outcome. METHODS: The French Network of Pulmonary Hypertension obtained data for 223 consecutive patients displaying idiopathic or familial PAH in whom point...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Bone Morphogenetic Protein Receptors, Type II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to France

Share to Germ-Line Mutation

Share to Hemodynamics

Share to Hypertension, Pulmonary

Share to Sequence Deletion

Share to Survival Rate

Source

Identifiers

PMID: 18356561
DOI: 10.1164/rccm.200712-1807OC

Genes

BMPR2
PAH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.PMID 18356561Read ↗

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.Semantic proximity Read ↗

Improved Survival of Patients with Pulmonary Arterial Hypertension with BMPR2 Mutations in the Last Decade.Semantic proximity Read ↗

Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis.Semantic proximity Read ↗

Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension.Semantic proximity Read ↗

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation.Semantic proximity Read ↗

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.Semantic proximity Read ↗

BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension.Semantic proximity Read ↗

Identification of a novel mutation in the BMPR2 gene in a pulmonary arterial hypertension patient using next-generation sequencing.Semantic proximity Read ↗

Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort.Semantic proximity Read ↗

BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.Semantic proximity Read ↗

Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.Semantic proximity Read ↗

The Genetics of Pulmonary Arterial Hypertension in the <i>Post‐BMPR2</i> EraSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.